According to this latest study, the 2020 growth of Diagnostic Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Diagnostic Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 3788.8 million in 2019. Over the next five years the Diagnostic Radiopharmaceuticals market will register a 7.2% CAGR in terms of revenue, the global market size will reach US$ 4995.7 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Consumption 2016-2026
2.1.2 Diagnostic Radiopharmaceuticals Consumption CAGR by Region
2.2 Diagnostic Radiopharmaceuticals Segment by Type
2.2.1 Technetium 99
2.2.2 Fluorine 18
2.2.3 Other
2.3 Diagnostic Radiopharmaceuticals Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2016-2021)
2.4 Diagnostic Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2016-2021)
2.5.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2016-2021)
3 Global Diagnostic Radiopharmaceuticals by Company
3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Company (2019-2021)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2019-2021)
3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2019-2021)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company
3.4 Global Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diagnostic Radiopharmaceuticals by Region
4.1 Global Diagnostic Radiopharmaceuticals by Region
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Region
4.2 Americas Diagnostic Radiopharmaceuticals Sales Growth
4.3 APAC Diagnostic Radiopharmaceuticals Sales Growth
4.4 Europe Diagnostic Radiopharmaceuticals Sales Growth
4.5 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Diagnostic Radiopharmaceuticals Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
5.1.2 Americas Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
5.2 Americas Diagnostic Radiopharmaceuticals Sales by Type
5.3 Americas Diagnostic Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals Sales by Region (2016-2021)
6.1.2 APAC Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021)
6.2 APAC Diagnostic Radiopharmaceuticals Sales by Type
6.3 APAC Diagnostic Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
7.2 Europe Diagnostic Radiopharmaceuticals Sales by Type
7.3 Europe Diagnostic Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diagnostic Radiopharmaceuticals Distributors
10.3 Diagnostic Radiopharmaceuticals Customer
11 Global Diagnostic Radiopharmaceuticals Market Forecast
11.1 Global Diagnostic Radiopharmaceuticals Forecast by Region
11.1.1 Global Diagnostic Radiopharmaceuticals Forecast by Regions (2021-2026)
11.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Diagnostic Radiopharmaceuticals Forecast by Type
11.7 Global Diagnostic Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Cardinal Health
12.1.1 Cardinal Health Cardinal Health Company Information
12.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Offered
12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Cardinal Health Main Business Overview
12.1.5 Cardinal Health Latest Developments
12.2 GE Healthcare
12.2.1 GE Healthcare Company Information
12.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Offered
12.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GE Healthcare Main Business Overview
12.2.5 GE Healthcare Latest Developments
12.3 Curium Pharma
12.3.1 Curium Pharma Company Information
12.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Offered
12.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Curium Pharma Main Business Overview
12.3.5 Curium Pharma Latest Developments
12.4 Jubilant Pharma
12.4.1 Jubilant Pharma Company Information
12.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered
12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Jubilant Pharma Main Business Overview
12.4.5 Jubilant Pharma Latest Developments
12.5 Bracco Imaging
12.5.1 Bracco Imaging Company Information
12.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered
12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bracco Imaging Main Business Overview
12.5.5 Bracco Imaging Latest Developments
12.6 Advanced Accelerator Applications
12.6.1 Advanced Accelerator Applications Company Information
12.6.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered
12.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Advanced Accelerator Applications Main Business Overview
12.6.5 Advanced Accelerator Applications Latest Developments
12.7 SIEMENS
12.7.1 SIEMENS Company Information
12.7.2 SIEMENS Diagnostic Radiopharmaceuticals Product Offered
12.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 SIEMENS Main Business Overview
12.7.5 SIEMENS Latest Developments
12.8 China Isotope & Radiation
12.8.1 China Isotope & Radiation Company Information
12.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered
12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 China Isotope & Radiation Main Business Overview
12.8.5 China Isotope & Radiation Latest Developments
12.9 Dongcheng Pharmaceutical Group
12.9.1 Dongcheng Pharmaceutical Group Company Information
12.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered
12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Dongcheng Pharmaceutical Group Main Business Overview
12.9.5 Dongcheng Pharmaceutical Group Latest Developments
12.10 Lantheus
12.10.1 Lantheus Company Information
12.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Offered
12.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Lantheus Main Business Overview
12.10.5 Lantheus Latest Developments
12.11 Eli Lilly
12.11.1 Eli Lilly Company Information
12.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Offered
12.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Eli Lilly Main Business Overview
12.11.5 Eli Lilly Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Diagnostic Radiopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Technetium 99
Table 3. Major Players of Fluorine 18
Table 4. Major Players of Other
Table 5. Global Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue by Type (2016-2021) & ($ million)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Table 9. Global Diagnostic Radiopharmaceuticals Sale Price by Type (2016-2021)
Table 10. Global Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 11. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 12. Global Diagnostic Radiopharmaceuticals Value by Application (2016-2021)
Table 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
Table 14. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2016-2021)
Table 15. Global Diagnostic Radiopharmaceuticals Sales by Company (2019-2021) & (K Units)
Table 16. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2019-2021)
Table 17. Global Diagnostic Radiopharmaceuticals Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
Table 19. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Diagnostic Radiopharmaceuticals Products Offered
Table 22. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) (K Units)
Table 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 27. Global Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 29. Americas Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 30. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 31. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 33. Americas Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 34. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 35. Americas Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 37. APAC Diagnostic Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 38. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 39. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 41. APAC Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 42. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 43. APAC Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 44. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 45. Europe Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 47. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 49. Europe Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 50. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 51. Europe Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 61. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)
Table 69. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 70. Cardinal Health Diagnostic Radiopharmaceuticals Product Offered
Table 71. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 72. Cardinal Health Main Business
Table 73. Cardinal Health Latest Developments
Table 74. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 75. GE Healthcare Diagnostic Radiopharmaceuticals Product Offered
Table 76. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 77. GE Healthcare Main Business
Table 78. GE Healthcare Latest Developments
Table 79. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 80. Curium Pharma Diagnostic Radiopharmaceuticals Product Offered
Table 81. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 82. Curium Pharma Main Business
Table 83. Curium Pharma Latest Developments
Table 84. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 85. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered
Table 86. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 87. Jubilant Pharma Main Business
Table 88. Jubilant Pharma Latest Developments
Table 89. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 90. Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered
Table 91. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. Bracco Imaging Main Business
Table 93. Bracco Imaging Latest Developments
Table 94. Advanced Accelerator Applications Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 95. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered
Table 96. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Advanced Accelerator Applications Main Business
Table 98. Advanced Accelerator Applications Latest Developments
Table 99. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 100. SIEMENS Diagnostic Radiopharmaceuticals Product Offered
Table 101. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. SIEMENS Main Business
Table 103. SIEMENS Latest Developments
Table 104. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 105. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered
Table 106. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. China Isotope & Radiation Main Business
Table 108. China Isotope & Radiation Latest Developments
Table 109. Dongcheng Pharmaceutical Group Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 110. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered
Table 111. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Dongcheng Pharmaceutical Group Main Business
Table 113. Dongcheng Pharmaceutical Group Latest Developments
Table 114. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 115. Lantheus Diagnostic Radiopharmaceuticals Product Offered
Table 116. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Lantheus Main Business
Table 118. Lantheus Latest Developments
Table 119. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 120. Eli Lilly Diagnostic Radiopharmaceuticals Product Offered
Table 121. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Eli Lilly Main Business
Table 123. Eli Lilly Latest Developments
List of Figures
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Diagnostic Radiopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Technetium 99
Figure 10. Product Picture of Fluorine 18
Figure 11. Product Picture of Other
Figure 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 14. Diagnostic Radiopharmaceuticals Consumed in Oncology
Figure 15. Global Diagnostic Radiopharmaceuticals Market: Oncology (2016-2021) & (K Units)
Figure 16. Diagnostic Radiopharmaceuticals Consumed in Cardiology
Figure 17. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2016-2021) & (K Units)
Figure 18. Diagnostic Radiopharmaceuticals Consumed in Other
Figure 19. Global Diagnostic Radiopharmaceuticals Market: Other (2016-2021) & (K Units)
Figure 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 21. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2020
Figure 22. Global Diagnostic Radiopharmaceuticals Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2020
Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Regions (2016-2021)
Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 26. Americas Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 27. Americas Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 28. APAC Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 29. APAC Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 30. Europe Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 31. Europe Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 34. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 35. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 37. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 38. United States Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 43. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Regions in 2020
Figure 44. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 45. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 46. China Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 53. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 54. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 55. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 56. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 65. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Diagnostic Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles